Paclitaxel, cisplatin and gemcitabine combination chemotherapy in stage IV non-small cell lung cancer (NSCLC):: A phase II study.

被引：0
|
作者：
Cortes, J
Rodriguez, J
Calvo, E
Martinez-Monge, R
Fernández-Hildago, O
Garzón, C
Santisteban, M
de Irala, J
Azinovic, I
Brugarolas, A
机构：
[1] Univ Navarra Clin, Pamplona, Spain
[2] Univ Navarra, E-31080 Pamplona, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
538P
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [2] A three drug combination chemotherapy with cisplatin, vinorelbine and gemcitabine for advanced non-small cell lung cancer A phase II study.
    Keren, S
    Tsalic, M
    Goralnik, L
    Siegelmann-Danieli, N
    Skigin, R
    Vardi, A
    Haim, N
    Milstein, D
    ANNALS OF ONCOLOGY, 2000, 11 : 112 - 112
  • [3] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [4] Treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) with Gemcitabine, ifosfamide, cisplatin (GIP): A phase II study
    Boni, C
    Bisagni, G
    Savoldi, L
    Moretti, G
    Vignoli, R
    Franciosi, V
    Pezzola, A
    De Pas, M
    Zadro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [5] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [6] Sequential chemotherapy with paclitaxel, cisplatin, Gemcitabine and vinorelbine in advanced non-small-cell lung cancer:: A phase II study.
    Barón, MG
    Ordóñez, A
    Martin, G
    Dorta, J
    Murias, A
    Madroñal, C
    Feliu, J
    Lizón, J
    Aguiar, J
    Vázquez, Y
    ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
  • [7] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [8] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [9] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [10] Phase II trial of gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy in unresectable stage III non-small cell lung cancer (NSCLC).
    Crino, L
    Mazzoni, F
    Maestri, A
    Calandri, C
    Selvaggi, G
    Scagliotti, GV
    De Marinis, F
    Gregorc, V
    Darwish, S
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
12345